1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Bakhu Holdings, Corp.

Bakhu Holdings, Corp.

BKUH
Bakhu Holdings, Corp.US flagOther OTC
0.00
USD
- -
- -
301,303.00Market Cap
Bakhu Holdings, Corp.
BKUH
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2008
2009
2010
2017
2018
2019
2020
2021
2022
2023
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
- -
-0.09
-0.15
-0.22
-0.41
-0.06
- -
-0.02
-0.05
-0.03
- -
Basic EPS, GAAP
- -
-0.09
-0.15
-0.03
-0.03
- -
- -
-0.01
-0.01
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.3
0.02
-0.12
-0.52
-0.42
-0.08
-0.05
-0.07
-0.12
-0.16
-0.16
Book Value per Share
0.02
0.03
-0.11
-0.34
- -
- -
- -
-0.01
-0.02
-0.03
-0.03
Tangible Book Value per Share
- -
- -
- -
- -
9
170
293
300
301
301
301
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
-4
-11
-1
-7
-15
-10
1
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
-2
-8
-10
-3
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
8
LT Debt
- -
- -
- -
- -
- -
- -
- -
-2
-7
-9
-10
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-2.11
Return on Capital (%)
- -
-86.96
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Oct'24
Jan'24
Apr'24
ST Debt
7
- -
- -
LT Borrowings
1
8
8
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
301
301
301
Market Capitalization
301
30
75

Working Capital

FRC

•

in mil. unless spec.
Oct'24
Jan'24
Apr'24
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
10
3
3
Payables & Accruals
3
3
3
ST Debt
7
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
478.87%
30.29%
Free Cash Flow
- -
77.14%
-83.29%
Net Income, GAAP
- -
140.42%
-33.37%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
-0.02
-0.02
-0.01
- -
-0.05
2023
-0.01
-0.01
-0.01
- -
-0.03
2024
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
Similar Companies
New You, Inc. (NWYU)
Mallinckrodt plc (MNK)
Cann Group Limited (CAN.AX)
Karo Pharma AB (publ) (KARO.ST)
Mojave Brands Inc. (MOJO.CN)
North Springs Resources Corp (NSRS)
Business
Bakhu Holdings, Corp. focuses on the production, manufacturing, and sale of cannabis-related byproducts, primarily targeting medical, food additive, and recreational markets. The company specializes in cannabis plant cell-extraction and replication technologies and offers proprietary equipment, processes, and medium formulations designed to produce cannabinoids such as cannabidiol (CBD) and tetrahydrocannabinol (THC). Its applications span medical use, food additives, and recreational cannabis products across North America, Central America, and the Caribbean. Bakhu Holdings operates through strategic joint ventures, sublicensing, and partnerships to commercialize its cannabis technologies and products. Founded in 2008 and headquartered in Long Beach, California, Bakhu Holdings was formerly known as Planet Resources, Corp. until its name change in May 2009. The company has recently undergone a major corporate restructuring aimed at facilitating future financing opportunities, including a proposed $10 million private placement through secured notes. This restructuring involves the cancellation of preferred stock with supervoting rights and an agreement that allows new investors to appoint a majority of the board, pending shareholder approval. These changes are designed to support growth and expand the company's commercialization efforts for its proprietary cannabis technologies. Bakhu Holdings continues to enhance its product and service offerings by leveraging its patented cell-extraction and replication processes to target the growing cannabis market with cannabinoid-based products. It operates exclusively in the pharmaceutical and biotech sector focusing on cannabis-derived compounds, emphasizing innovation in cannabinoid production and commercialization strategies. Its ongoing strategic plans include expanding its market presence through joint ventures and licensing agreements to access a wider range of geographic markets throughout the Americas. The company remains in a development stage, actively pursuing funding and operational scaling to advance its product commercialization.